Related Experiment Video

Updated: Aug 24, 2026

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors

Stephanie Blencke1, Birgit Zech, Ola Engkvist

  • 1Axxima Pharmaceuticals AG, Max-Lebsche-Platz 32, 81377 Munich, Germany.

Chemistry & Biology
|May 26, 2004
PubMed

Insights

Protein kinase mutations at the ATP binding site can cause resistance to small molecule inhibitors. Indolinones, however, effectively inhibit both wild-type and mutated kinases, offering new therapeutic avenues.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Protein kinases are crucial in cell signaling.
  • Resistance to small molecule inhibitors is a major challenge in kinase-targeted therapies.
  • Mutations in the ATP binding site can confer drug resistance.

Purpose of the Study:

  • To investigate the impact of mutations at a conserved threonine residue in the ATP binding site of protein kinases.
  • To determine the cellular sensitivity of disease-relevant tyrosine kinases to various inhibitors.
  • To explore the potential of indolinones as inhibitors for both wild-type and resistant kinase mutants.

Main Methods:

  • Comprehensive mutational analysis of the ATP binding site in protein kinases.
  • Cellular sensitivity assays using various small molecule inhibitors (ZD1839, PP1, AG1296, STI571, pyrido[2,3-d]pyrimidine, indolinones).
  • Pharmacological analysis of beta-platelet-derived growth factor (PDGF) receptor signaling and generation of a drug-inducible cellular Src kinase activity system.

Main Results:

  • Mutant kinases with larger side chains at the critical site exhibited resistance to most tested inhibitors.
  • Indolinone inhibitors demonstrated similar potency against both wild-type and mutant kinases.
  • Resistant mutants facilitated the study of beta-PDGF receptor signaling and the development of inducible kinase activity systems.

Conclusions:

  • A conserved structural determinant in protein kinases influences sensitivity to small molecule inhibitors.
  • Indolinones represent a promising class of inhibitors for overcoming resistance.
  • Findings are relevant for both signal transduction research and the development of novel kinase-targeted drugs.

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...